It is important to acknowledge that the high prevalence of certain mutations in our thrombophilia group—particularly PAI-1 4G/4G (98%) and MTHFR C677T (76%)—substantially exceeds reference frequencies reported in the general European population. The gene discussed is MTHFR; the disease is thrombophilia.